The estimated Net Worth of A Kelly Michael is at least $13.8 Million dollars as of 25 April 2014. A Michael owns over 2,065 units of AMGEN stock worth over $13,542,709 and over the last 19 years A sold AMGN stock worth over $228,079.
A has made over 1 trades of the AMGEN stock since 2014, according to the Form 4 filled with the SEC. Most recently A sold 2,065 units of AMGN stock worth $228,079 on 25 April 2014.
The largest trade A's ever made was selling 2,065 units of AMGEN stock on 25 April 2014 worth over $228,079. On average, A trades about 69 units every 0 days since 2006. As of 25 April 2014 A still owns at least 41,041 units of AMGEN stock.
You can see the complete history of A Michael stock trades at the bottom of the page.
A's mailing address filed with the SEC is ONE AMGEN CENTER DRIVE, , THOUSAND OAKS, CA, 91320-1799.
Over the last 21 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer und Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
AMGEN executives and other stock owners filed with the SEC include: